Impaired expression in DA rats of catalytically active P450BTL, immunochemically distinguishable from P4502D1: Immunological evidence with specific anti-peptide antibodies

Biomedical Research

Volumn 17, Issue 5, 1996, Pages 331-337

  Yamamoto, Yukio ^a   Nakamura, Akio ^a,b   Tasaki, Takafumi ^a   Umeda, Shin ^c   Sugimoto, Chihiro ^a   Imaoka, Susumu ^d   Funae, Yoshihiko ^d   Masuda, Makihiko ^a   Kazusaka, Akio ^a   Fujita, Shoichi ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

^b NIPPON SHINYAKU CO LTD   (Japan)

^c CHIBA UNIVERSITY   (Japan)

^d OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BUNITROLOL; CYTOCHROME P450; DEBRISOQUINE; OXYGENASE; POLYCLONAL ANTIBODY;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CROSS REACTION; ENZYME ACTIVITY; ENZYME PURIFICATION; FEMALE; HYDROXYLATION; IMMUNOCHEMISTRY; IMMUNOREACTIVITY; LIVER MICROSOME; MALE; METABOLISM; NONHUMAN; PROTEIN EXPRESSION; RAT; REGRESSION ANALYSIS;

ANIMALIA; RATTUS NORVEGICUS;

EID: 10544228953     PISSN: 03886107     EISSN: None     Source Type: Journal    
DOI: 10.2220/biomedres.17.331     Document Type: Article

References (22)

1. AL-DABBAGH S. G., IDLE J. R. and SMITH R. L. (1981) Animal modelling of human polymorphic drug oxidation-the metabolism of debrisoquine and phenacetin in rat inbred strains. J. Pharm. Pharmacol. 33, 161-164
2. BOOBIS A. R., SEDDON C. E. and DAVIES D. S. (1986) Bufuralol 1′-hydroxylase activity of the rat. Strain differences and the effects of inhibitors. Biochem. Pharmacol. 35, 2961-2965
3. BROSEN K. (1990) Recent developments in hepatic drug oxidation. Implications for clinical pharmacokinetics. Clin. Pharmacokinet. 18, 220-239
4. FUNAE Y. and IMAOKA S. (1985) Simultaneous purification of multiple forms of rat liver microsomal cytochrome P-450 by high-performance liquid chromatography. Biochim. Biophys. 842, 119-132
5. GONZALEZ F. J. (1988) The molecular biology of cytochrome P450s. Pharmacol. Rev. 40, 243-288
6. GONZALEZ F. J., MATSUNAGA T., NAGATA K., MEYER U. A., NEBERT D. W., PASTEWKA J., KOZAK C. A., GILLETTE J., GELBOIN H. V. and HARDWICK J. P. (1987) Debrisoquine 4-hydroxylase: characterization of a new P450 gene subfamily, regulation, chromosomal mapping, and molecular analysis of the DA rat polymorphism. DNA 6, 149-161
7. GONZALEZ F. J., SKODA R. C., KIMURA S., UMENO M., ZANGER U. M., NEBERT D. W., GELBOIN H. V., HARDWICK J. P. and MEYER U. A. (1988) Characterization of the common genetic defect in humans deficient in debrisoquine metabolism. Nature 331, 442-446
8. ISHIDA R., FUJITA S. and SUZUKI T. (1988) Bunitrolol metabolism and its inhibition by cimetidine. J. Pharm. Pharmacol. 40, 64-65
9. KAHN G. C., RUBENFIELD M., DAVIES D. S., MURRAY S. and BOOBIS A. R. (1985) Sex and strain differences in hepatic debrisoquine 4-hydroxylase activity of the rat. Drug Metab. Dispos. 13, 510-516
10. LAEMMLI U. K. (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680-685
11. LARREY D., DISTLERATH L. M., DANNAN G. A., WILKINSON G. R. and GUENGERICH F. P. (1984) Purification and characterization of the rat liver microsomal cytochrome P-450 involved in the 4-hydroxylation of debrisoquine, a prototype for genetic variation in oxidative drug metabolism. Biochemistry 23, 2787-2795
12. LENNARD P. R. (1990) Image analysis for all. Nature 347, 103-104
13. LOWRY O. H., ROSEBROUGH N. J., FARR A. L. and RANDALL R. J. (1951) Protein measurement with the folin phenol reagent. J. Biol. Chem. 193, 265-275
14. MASUBUCHI Y., FUJITA S., CHIBA M., KAGIMOTO N., UMEDA S. and SUZUKI T. (1991) Impairment of debrisoquine 4-hydroxylase and related monooxygenase activities in the rat following treatment with propranolol. Biochem. Pharmacol. 41, 861-865
15. MATSUNAGA E., UMENO M. and GONZALEZ F. J. (1990) The rat P450 IID subfamily: complete sequences of four closely linked genes and evidence that gene conversions maintained sequence homogeneity at the heme-binding region of the cytochrome P450 active site. J. Mol. Evol. 30, 155-169
16. MATSUNAGA E., ZANGER U. M., HARDWICK J. P., GELBOIN H. V., MEYER U. A. and GONZALEZ F. J. (1989) The CYP2D gene subfamily: analysis of the molecular basis of the debrisoquine 4-hydroxylase deficiency in DA rats. Biochemistry 28, 7349-7355
17. NAKAMURA A., YAMAMOTO Y., TASAKI T., SUGIMOTO C., MASUDA M., KAZUSAKA A. and FUJITA S. (1995) Anti-peptide antibodies to the P4502d subfamily in rat, dog and man. Xenobiotica 25, 1103-1109
18. NELSON D. R., KOYMANS L., KAMATAKI T., STEGEMAN J. J., FEYEREISEN R., WAXMAN D. J., WATERMAN M. R., GOTOH O., COON M. J., ESTABROOK R. W., GUNSALUS I. C. and NEBERT D. W. (1996) P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature. Pharmacogenetics 6, 1-42
19. OHISHI N., IMAOKA S., SUZUKI T. and FUNAE Y. (1993) Characterization of two P-450 isozymes placed in the rat CYP2D subfamily. Biochim. Biophys. Acta 1158, 227-236
20. OMURA T. and SATO R. (1964) The carbon monoxide-binding pigment of liver microsomes. J. Biol. Chem. 239, 2379-2385
21. SUZUKI T., NARIMATSU S., FUJITA S., MASUBUCHI Y. and UMEDA S. (1991) Impairment of bunitrolol 4-hydroxylase activity in liver microsomes of dark agouti rats. Biochem. Pharmacol. 42, 2241-2244
22. SUZUKI T., NARIMATSU S., FUJITA S., MASUBUCHI Y., UMEDA S., IMAOKA S. and FUNAE Y. (1992) Purification and characterization of a cytochrome P-450 isozyme catalyzing bunitrolol 4-hydroxylation in liver microsomes of male rats. Drug Metab. Dispos. 20, 367-373